Long-term prognostic effect of hormone receptor subtype on breast cancer.
Ki-Tae HwangJongjin KimJiwoong JungByoung Hyuck KimJeong Hwan ParkSook Young JeonKyu Ri HwangEun Youn RohJin Hyun ParkSu-Jin KimPublished in: Breast cancer research and treatment (2019)
Hormone receptor subtype is a significant independent prognostic factor in female operable invasive breast cancer patients with long-term effect. The ER(+)/PR(+) subtype shows the most favorable prognosis, followed by ER(+)/PR(-), ER(-)/PR(+), and ER(-)/PR(-) subtypes in the respective order. Prognostic impacts of hormone receptor subtypes are also maintained in subgroup analysis according to anatomic stage, race, age, and year of diagnosis.